Strive, Inc. (ASST) Stock Price & Analysis
Strive, Inc. (ASST) rose 0.00% to USD 11.49 as of July 25, 2026 at 06:12 UTC, according to Nexqual real-time market data.
ASST last closed at USD 11.49; the session ranged USD 11.43–12.21 on volume of 2,183,972 shares. Market capitalization is —, with a 52-week range of USD 7.02–252 (NGM). Source: Nexqual, July 25, 2026 at 06:12 UTC.
Key Statistics (as of July 25, 2026 at 06:12 UTC)
| Price | USD 11.49 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 11.49 |
| Open | USD 11.49 |
| Day Range | USD 11.43 – 12.21 |
| 52-Week Range | USD 7.02 – 252 |
| Volume | 2,183,972 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (ASST)
Nexqual's technical model rates ASST "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 06:12 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 42.17 (neutral) |
| vs SMA50 | Below (USD 14.37) |
| MACD | -0.53 (negative) |
Financial Health Score (ASST)
Nexqual rates Strive, Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 06:12 UTC.
| Growth | Strong — Revenue +94% YoY (latest Q) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $146M cash vs $13M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$321M, burning cash |
| Efficiency | Critical — ROE -124%, ROA -62.6% |
From Strive, Inc.'s Latest SEC 10-K Filing (filed 2026-03-19)
Key Strengths & Strategy (as disclosed to the SEC)
- Our Healthcare Technology Solutions Products and Services Our subsidiary, Semler Scientific, currently markets a patented and FDA-cleared, vascular testing product, QuantaFlo.
- Semler Scientific previously reported that it is experiencing and expects to continue to experience decreased usage of its QuantaFlo device due various factors, including the 2024 Medicare Advantage and Part D Final Rate Announcement issued by the Centers for Medicare and Medicaid Services ("CMS").
- Executive Branch, Congress and a number of U.S. federal and state agencies, including the Financial Crimes Enforcement Network, the Commodity Futures Trading Commission ("CFTC"), the U.S.
- A blood flow waveform is instantaneously constructed by our proprietary software algorithm.
Partnerships
- Semler Scientific has been cooperating with civil investigative demands from DOJ (as defined below) since 2017 related to claims for reimbursement related to Semler Scientific's QuantaFlo device and entered into a settlement agreement with DOJ related thereto in September 2025.
- Relative to a traditional depreciating fiat-denominated benchmark, implementing a bitcoin hurdle rate establishes a higher level of accountability and strategic investment discipline, since our decisions are measured against an asset we believe will appreciate over time.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GPUS | Hyperscale Data, Inc. | USD 0.13 | ▼ 3.62% |
| SBET | SharpLink, Inc. | USD 5.81 | ▼ 8.07% |
| CIFR | Cipher Digital Inc. | USD 23.15 | ▼ 5.36% |
| DVLT | Datavault AI Inc. | USD 0.36 | ▼ 6% |
| NAKA | Nakamoto Inc. | USD 4.87 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 06:12 UTC. This page is informational and not investment advice.